Brightspring Health Services, Inc. (BTSG) Stock Price & Analysis
Brightspring Health Services, Inc. (BTSG) fell 1.14% to USD 60.73 as of September 8, 2026 at 05:01 UTC, according to Nexqual real-time market data.
BTSG last closed at USD 60.73; the session ranged USD 60.51–61.75 on volume of 1,729,143 shares. Market capitalization is —, with a 52-week range of USD 25.06–73.75 (NMS). Source: Nexqual, September 8, 2026 at 05:01 UTC.
Key Statistics (as of September 8, 2026 at 05:01 UTC)
| Price | USD 60.73 |
|---|---|
| Change | ▼ 1.14% (down) |
| Previous Close | USD 60.73 |
| Open | USD 60.73 |
| Day Range | USD 60.51 – 61.75 |
| 52-Week Range | USD 25.06 – 73.75 |
| Volume | 1,729,143 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BTSG)
Nexqual's technical model rates BTSG "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 05:01 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.93 (neutral) |
| vs SMA50 | Below (USD 65.1) |
| MACD | -1.12 (negative) |
From Brightspring Health Services, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- In 2020, we also completed the implementation of a financial systems transformation, including the implementation of Oracle Fusion and a new budgeting and forecasting system.
- We believe that we are positioned to identify potential medical problems and avoid adverse events due to our highly proximate position to patients. • Market-leading scale with a focus on operational excellence and coordinated front-line care – We manage one of the nation's largest independent platforms of both pharmacy and provider services offered on a daily basis in home and community settings – to address the multiple needs of medically complex Senior and Specialty patients.
- Over $40 billion in annual U.S. health care spending is attributed to hospital readmissions, and home health care can reduce 365-day post-discharge costs by more than $6,000 per patient, each per the American Journal of Medicine.
- Scale from our pharmacy and provider businesses allow us to effectively deliver and coordinate integrated solutions to and across patient types and care settings, which we believe will be more important in the ongoing development of value-based care solutions.
Partnerships
- On January 17, 2025, we entered into a purchase agreement with National Mentor Holding, Inc. to divest the Company's community living services, home and community based waiver programs, and intermediate care facilities (the "Community Living business"), for $835 million, subject to typical adjustments for working capital and other customary items.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNEX | StoneX Group Inc. | USD 69.46 | ▲ 3.89% |
| PACS | PACS Group, Inc. | USD 42.5 | ▼ 1.37% |
| WAY | Waystar Holding Corp. | USD 25.07 | ▼ 2.53% |
| INDV | Indivior Pharmaceuticals, Inc. | USD 34.94 | ▼ 0.31% |
| CSTM | Constellium SE | USD 27.14 | ▲ 2.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:01 UTC. This page is informational and not investment advice.